BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30515161)

  • 21. Protection Against Invasive Infections in Children Caused by Encapsulated Bacteria.
    Sadarangani M
    Front Immunol; 2018; 9():2674. PubMed ID: 30515161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations.
    Adderson EE
    Springer Semin Immunopathol; 2001 Dec; 23(4):387-403. PubMed ID: 11826616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of Susceptibility to Disseminated Infection with IgA1 Protease-Producing Encapsulated Pathogens Streptococcus pneumoniae, Haemophilus influenzae Type b, and Neisseria meningitidis.
    Kilian M; Husby S; Andersen J; Moldoveanu Z; Sørensen UBS; Reinholdt J; Tettelin H
    mBio; 2022 Jun; 13(3):e0055022. PubMed ID: 35420467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changing epidemiology of bacterial meningitis and invasive non-meningitic bacterial disease in scotland during the period 1983-99.
    Kyaw MH; Christie P; Jones IG; Campbell H
    Scand J Infect Dis; 2002; 34(4):289-98. PubMed ID: 12064693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens.
    Mond JJ; Kokai-Kun JF
    Curr Top Microbiol Immunol; 2008; 319():17-40. PubMed ID: 18080413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An association between homozygous C3 deficiency and low levels of anti-pneumococcal capsular polysaccharide antibodies.
    Hazlewood MA; Kumararatne DS; Webster AD; Goodall M; Bird P; Daha M
    Clin Exp Immunol; 1992 Mar; 87(3):404-9. PubMed ID: 1544226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing a vaccine for
    Cox AD; Barreto L; Ulanova M; Bruce MG; Tsang R;
    Can Commun Dis Rep; 2017 May; 43(5):89-95. PubMed ID: 29770071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: A solution for an unmet public health need.
    Cox AD; Williams D; Cairns C; St Michael F; Fleming P; Vinogradov E; Arbour M; Masson L; Zou W
    Vaccine; 2017 Oct; 35(45):6129-6136. PubMed ID: 28951087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The changing epidemiology of invasive Haemophilus influenzae disease: Emergence and global presence of serotype a strains that may require a new vaccine for control.
    Tsang RSW; Ulanova M
    Vaccine; 2017 Jul; 35(33):4270-4275. PubMed ID: 28666758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study.
    Parikh SR; Andrews NJ; Beebeejaun K; Campbell H; Ribeiro S; Ward C; White JM; Borrow R; Ramsay ME; Ladhani SN
    Lancet; 2016 Dec; 388(10061):2775-2782. PubMed ID: 28100432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.
    Kwatra G; Adrian PV; Shiri T; Buchmann EJ; Cutland CL; Madhi SA
    Clin Microbiol Infect; 2015 Jun; 21(6):568.e13-21. PubMed ID: 25680313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada.
    Nix EB; Williams K; Cox AD; St Michael F; Romero-Steiner S; Schmidt DS; McCready WG; Ulanova M
    Emerg Infect Dis; 2015 Feb; 21(2):273-9. PubMed ID: 25626129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants.
    Dangor Z; Kwatra G; Izu A; Lala SG; Madhi SA
    Expert Rev Vaccines; 2015 Jan; 14(1):135-49. PubMed ID: 25242617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.
    Andrews NJ; Waight PA; Burbidge P; Pearce E; Roalfe L; Zancolli M; Slack M; Ladhani SN; Miller E; Goldblatt D
    Lancet Infect Dis; 2014 Sep; 14(9):839-46. PubMed ID: 25042756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.
    Martin NG; Sadarangani M; Pollard AJ; Goldacre MJ
    Lancet Infect Dis; 2014 May; 14(5):397-405. PubMed ID: 24631222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster.
    Perrett KP; John TM; Jin C; Kibwana E; Yu LM; Curtis N; Pollard AJ
    Clin Infect Dis; 2014 Apr; 58(7):949-59. PubMed ID: 24403544
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.